N. Arvind Dasari is a Professor and Director of Clinical Research at MD Anderson Cancer Center, specializing in gastrointestinal cancers. With a background from the University of Pittsburgh, he is a leader in clinical trials for neuroendocrine tumors and colorectal cancer, and serves as co-chair for national committees like the SWOG Neuroendocrine Subcommittee.
He was the lead investigator for the global FRESCO-2 Phase III trial, presenting findings that support a new, practice-changing treatment option for patients with refractory metastatic colorectal cancer.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.